Gufic Biosciences Limited (NSE:GUFICBIO)

Gufic Biosciences Revenue

In the fiscal year ending March 31, 2026, Gufic Biosciences had annual revenue of 9.44B INR with 15.15% growth. Gufic Biosciences had revenue of 2.52B in the quarter ending March 31, 2026, with 22.83% growth.

• Revenue: 9.44B
• Revenue Growth: +15.15%
• P/S Ratio: 3.78
• Revenue / Employee: 6.36M
• Employees: 1,484
• Market Cap: 35.70B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	9.44B	1.24B	15.15%
Mar 31, 2025	8.20B	131.40M	1.63%
Mar 31, 2024	8.07B	1.16B	16.80%
Mar 31, 2023	6.91B	-885.35M	-11.36%
Mar 31, 2022	7.79B	2.91B	59.76%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error